Tuberculosis associated with TNF-alpha antagonists

M. Seiscento, B. Sidney, S. K. B. Roberta, F. R. Viviane, C. Rafael, L. M. M. Ieda, V. S. Francisco (Sao Paulo, Brazil)

Source: Annual Congress 2006 - Immunological diagnosis of tuberculosis infection and disease
Session: Immunological diagnosis of tuberculosis infection and disease
Session type: Poster Discussion
Number: 885
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Seiscento, B. Sidney, S. K. B. Roberta, F. R. Viviane, C. Rafael, L. M. M. Ieda, V. S. Francisco (Sao Paulo, Brazil). Tuberculosis associated with TNF-alpha antagonists. Eur Respir J 2006; 28: Suppl. 50, 885

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1? synthesis by human neutrophils
Source: Eur Respir J 2011; 37: 406
Year: 2011



Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Novel approach to prevention of dust-induced acute lung injury with interleukin-1 receptor antagonist (IL-1ra)
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003

Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009


Allelic polymorphism of IL-4 and IL-10 genes as underlying factor in the production of cytokines and rate of recurrent pulmonary tuberculosis(RPTB)
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Tuberculosis and tumor necrosis factor alpha antagonist: Our experience
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012

Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma
Source: Eur Respir J 2007; 29: 502-508
Year: 2007



Alpha-1-antitrypsin regulates IL-8 release and CXCR2 expression in human neutrophils
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Susceptibility to chronic bacterial purulent rhinosinusitis is associated with the combination of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphic alleles
Source: Eur Respir J 2005; 26: Suppl. 49, 406s
Year: 2005

The treatment of bleomycin-induced lung injury with combination of antioxidants and interleukin-1 receptor antagonist (IL-1ra)
Source: Eur Respir J 2002; 20: Suppl. 38, 488s
Year: 2002

Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 366s
Year: 2001

Study of the Association of Functional Polymorphisms Affecting the TLR2, TIRAP, TNF, IL1B, IL1RN, IL12B and NOS2A Genes with Susceptibility to Pulmonary Tuberculosis.
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Tuberculosis in patients on TNFa inhibitor treatment in Latvia.
Source: International Congress 2017 – Migrants and screening
Year: 2017

The dual endothelin receptor antagonist bosentan reduces TNFα induced GM-CSF release more effectively than the endothelin A receptor antagonist ambrisentan
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010

Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1510-1512
Year: 2015